Histochemical and Molecular Genetic Study of MELAS and MERRF in Korean Patients.
10.3346/jkms.2002.17.1.103
- Author:
Dae Seong KIM
1
;
Dae Soo JUNG
;
Kyu Hyun PARK
;
In Joo KIM
;
Cheol Min KIM
;
Won Ho LEE
;
Soon Ki RHO
Author Information
1. Department of Neurology, College of Medicine, Pusan National University, Pusan, Korea. dskim@pusan.ac.kr
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
MELAS Syndrome;
MERRF Syndrome;
Korea
- MeSH:
Adolescent;
Adult;
Electron Transport Complex IV/metabolism;
Female;
Humans;
Korea;
MELAS Syndrome/*genetics/metabolism/*pathology;
MERRF Syndrome/*genetics/metabolism/*pathology;
Male;
Pedigree;
Polymerase Chain Reaction/methods;
Polymorphism, Restriction Fragment Length;
RNA, Transfer;
Sequence Analysis, DNA
- From:Journal of Korean Medical Science
2002;17(1):103-112
- CountryRepublic of Korea
- Language:English
-
Abstract:
Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode (MELAS) and myoclonic epilepsy and raggedred fibers (MERRF) are rare disorders caused by point mutation of the tRNA gene of the mitochondrial genome. To understand the pathogenetic mechanism of MELAS and MERRF, we studied four patients. Serially sectioned frozen muscle specimens with a battery of histochemical stains were reviewed under light microscope and ultrastructural changes were observed under electron microscope. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis was performed and the tRNA genes were sequenced to confirm mutations. In two patients with MELAS, strongly succinyl dehydrogenase positive blood vessels (SSVs) and many cytochrome oxidase (COX) positive raggedred fibers (RRFs) were observed, and A3243G mutations were found from the muscle samples. In two patients with MERRF, neither SSV nor COX positive RRFs were seen and A8344G mutations were found from both muscle and blood samples. In the two MERRF families, the identical mutation was observed among family members. The failure to detect the mutation in blood samples of the MELAS suggests a low mutant load in blood cells. The histochemical methods including COX stain are useful for the confirmation and differentiation of mitochondrial diseases. Also, molecular biological study using muscle sample seems essential for the confirmation of the mtDNA mutation.